Mevalonate kinase deficiency and Dutch type periodic fever.

Dutch type periodic fever (DPF) is an autosomal recessive hereditary fever syndrome. Cases have been reported worldwide, the majority from France and The Netherlands. From infancy the patients suffer fever attacks that recur every 2-8 weeks, often precipitated by immunizations, infections or emotional stress. Fever lasts 2-7 days and can be accompanied by malaise, headache, diarrhea, abdominal pain, vomiting, skin rashes, arthralgia, arthritis, tender lymphadenopathy, hepatosplenomegaly, and oral and genital ulcers. Laboratory evaluation during fever shows granulocytosis and elevated acute phase reactants. DPF is caused by a deficiency of the enzyme mevalonate kinase (MK). Besides DPF, the spectrum of MK deficiency includes a severe phenotype, mevalonic aciduria (MA). MA patients have less residual MK activity, leading to substantially higher urinary mevalonic acid excretion than in DPF. Mevalonic aciduria is characterized by mental retardation and dysmorphic features in addition to the clinical features of DPF. At the genomic level, several mutations of varying severity have been identified. The DPF phenotype is caused by one particular mild missense mutation. Most patients are compound heterozygotes for this mutation and a more severe mutation. The mechanism by which MK deficiency leads to fever is not understood. The vast majority of DPF patients have persistently elevated serum IgD and can be classified as having hyperimmunoglobulinemia D and periodic fever syndrome (HIDS). Conversely, most HIDS patients have MK deficiency and hence DPF, but the two disorders do not overlap entirely.

[1]  J. Frenkel Periodic fever and mevalonate kinase deficiency , 2002 .

[2]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[3]  J. Drenth,et al.  Genes associated with periodic fevers highlighted at Dutch workshop , 1999, The Lancet.

[4]  S. Ozen New interest in an old disease: familial Mediterranean fever. , 1999, Clinical and experimental rheumatology.

[5]  H. Waterham,et al.  Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis. , 1999, Human molecular genetics.

[6]  M. Rolland,et al.  Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry. , 1999, American journal of human genetics.

[7]  J. Kouyoumdjian,et al.  MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. , 1999, American journal of human genetics.

[8]  D. Zemer,et al.  Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. , 1999, The Journal of pediatrics.

[9]  H. Waterham,et al.  Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome , 1999, Nature Genetics.

[10]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[11]  M. Gubler,et al.  Crescentic glomerulonephritis in hyper IgD syndrome , 1999, Pediatric Nephrology.

[12]  S. Rivière,et al.  La fièvre qui venait du nord , 1999 .

[13]  J. Derry,et al.  Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com. , 1999, Nature genetics.

[14]  A. Moser,et al.  Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. , 1999, Nature genetics.

[15]  E. Lelièvre,et al.  T(h)2 cytokine dependence of IgD production by normal human B cells. , 1999, International immunology.

[16]  D. Booth,et al.  Pyrin/marenostrin mutations in familial Mediterranean fever. , 1998, QJM : monthly journal of the Association of Physicians.

[17]  P. Vreken,et al.  Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. , 1998, American journal of human genetics.

[18]  G. Utermann,et al.  Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. S. Lin,et al.  Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. , 1998, American journal of human genetics.

[20]  Y. Chaix,et al.  Pseudomaladie périodique avec hyperimmunoglobulinémie D: une histoire sans fin de début anténatal probable , 1998 .

[21]  R. Winter,et al.  Clinical phenotype of desmosterolosis. , 1998, American journal of medical genetics.

[22]  K. Gibson,et al.  Identification of an Active Site Alanine in Mevalonate Kinase through Characterization of a Novel Mutation in Mevalonate Kinase Deficiency* , 1997, The Journal of Biological Chemistry.

[23]  R. Powell,et al.  Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. , 1997, Mayo Clinic proceedings.

[24]  Jacques Demaille,et al.  A candidate gene for familial Mediterranean fever , 1997, Nature Genetics.

[25]  M. Pras,et al.  Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features. , 1997, The Journal of rheumatology.

[26]  J. V. D. van der Meer,et al.  Hyper-IgD syndrome and pregnancy. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[27]  M. Daha,et al.  Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells , 1996, Immunology.

[28]  J. V. D. van der Meer,et al.  Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. , 1996, Journal of immunology.

[29]  C. Grose,et al.  Children with hyperimmunoglobulinemia D and periodic fever syndrome. , 1996, The Pediatric infectious disease journal.

[30]  J. Meer,et al.  Interferon‐γ and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome , 1995, European journal of clinical investigation.

[31]  J. V. D. van der Meer,et al.  Elevated serum level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation. , 1995, Clinical immunology and immunopathology.

[32]  C. Schalkwijk,et al.  Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. , 1995, Blood.

[33]  J. V. D. van der Meer,et al.  Hyperimmunoglobulinemia D and Periodic Fever Syndrome: The Clinical Spectrum in a Series of 50 Patients , 1994, Medicine.

[34]  J. V. D. van der Meer,et al.  Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. , 1994, Archives of dermatology.

[35]  K. Sartor,et al.  Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. , 1993, Pediatrics.

[36]  T. Shirai,et al.  Association of hyperimmunoglobulinaemia D syndrome with erythema eievatum diutinum , 1993, The British journal of dermatology.

[37]  K. Gibson,et al.  Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria. , 1992, The Journal of biological chemistry.

[38]  R. Topaloğlu,et al.  Hyperimmunoglobulinaemia D and periodic fever mimicking familial Mediterranean fever in the Mediterranean. , 1991, Postgraduate medical journal.

[39]  K. Gibson,et al.  3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. , 1990, Journal of lipid research.

[40]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[41]  K. Gibson,et al.  Mevalonic aciduria--an inborn error of cholesterol and nonsterol isoprene biosynthesis. , 1986, The New England journal of medicine.

[42]  H. Schierbeek,et al.  Mevalonic aciduria: an inborn error of cholesterol biosynthesis? , 1985, Clinica chimica acta; international journal of clinical chemistry.

[43]  R. Furth,et al.  HYPERIMMUNOGLOBULINAEMIA D AND PERIODIC FEVER: A NEW SYNDROME , 1984, The Lancet.

[44]  A. Prieur,et al.  Aspect nosologique des formes systématiques darthrite juvénile à début très précoce: à propos de dix-sept observations , 1984 .